Record MS-N196 · Supportive care · Last literature search and appraisal: 31 October 2026
Evidence at a glance
- Evidence label: Promising early-phase evidence
- Potential benefit: Six weekly Swedish-massage sessions produced a clinically meaningful average fatigue reduction in a small trial and outperformed both light touch and waitlist.
- Risk: No serious adverse events were reported; discomfort from positioning occurred and oncology-specific precautions still apply.
- What this evidence is about: Persistent fatigue after breast-cancer treatment; it does not establish any effect on recurrence or survival.
What was studied
Sixty-six stage 0–III breast-cancer survivors with persistent fatigue were randomized to 45-minute weekly Swedish massage, matched light touch or waitlist for six weeks; 57 were evaluable. Mean Multidimensional Fatigue Inventory change was −16.50 with massage, −8.06 with light touch and +5.88 with waitlist (treatment-by-time P<0.0001). The massage change exceeded the study’s 10-point clinically meaningful threshold. PROMIS fatigue also favored massage. Participants and therapists could not be masked, but the comparison with light touch helps separate technique from attention.
What the evidence cannot establish
Early-phase, single-site, small sample, women with breast cancer only and six-week horizon. Nine randomized participants were not evaluable, although 56/57 evaluable participants completed follow-up. Full text was reviewed. The study reports NIH funding; conflict details should be checked in the paper.
Symptom improvement is not evidence of tumor shrinkage, delayed recurrence or longer survival. This record does not support replacing oncology treatment.
Practical safety context
Adverse events were assessed at every visit. The common events were venipuncture bruising (12/39 active-treatment participants) and discomfort from massage-table hyperextension (2/39); no serious adverse events or between-group differences were reported. Positioning and pressure should be tailored.
Questions for the care team
- Have anemia, thyroid dysfunction, sleep disorder, depression, medication effects and recurrence concerns been assessed?
- Can massage be safely adapted to scars, lymphedema risk, neuropathy or bone health?
- What will we do if fatigue does not improve after a defined trial?
Sources checked
Source note: Publication dates refer to the indexed paper; links were checked on 31 October 2026. A registry entry verifies design or status, not efficacy. Unreported fields are not assumed to be absent.
Education only: This evidence summary is not personal medical advice. Decisions about symptoms, treatment interactions and complementary care belong with your oncology team.
